By Andrew Silver SHANGHAI (Reuters) -Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

Sonia Saxena’s five-year weight loss journey transformed her from an overwhelmed mother at 80 kg to a disciplined, empowered ...

Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied ...

In a new study, one intermittent fasting strategy came out on top, and even beat traditional calorie cutting. But you should ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

Chia seeds are tiny black or white seeds and have become a part of the morning routine for many of us. Packed with fiber, ...

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...